Our Lady of the Lake Heart & Vascular Institute Joins the Cardiometabolic Center Alliance as a Charter Member

May 16, 2023

The Cardiometabolic Center Alliance is a national collaborative of healthcare organizations committed to improving the quality of care and outcomes in patients with cardiometabolic disease.

BATON ROUGE, LA—The Cardiometabolic Center Alliance (CMCA), founded by Saint Luke’s Mid America Heart Institute, is honored to announce the addition of Our Lady of the Lake Heart & Vascular Institute as a Charter Member.

The Cardiometabolic Center Alliance is a national collaborative of healthcare organizations committed to improving the quality of care and outcomes in patients with cardiometabolic disease. Alliance members adopt and implement a novel care model designed and successfully implemented by Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence in Kansas City, MO. Based on the initial data, under this model the rates of optimal guideline-directed medical therapy substantially increased over the national average, ensuring that patients with T2D receive care that is aimed at both optimizing diabetes management and providing comprehensive cardiovascular risk reduction with therapies proven to improve outcomes. These results are made possible by a unified team of clinicians from across the disease continuum who focus on holistic, guideline-directed preventative care.

Through their participation, Alliance members contribute to a national registry that tracks treatment patterns and quality of care. As the Alliance enhances its capabilities, improves processes, and expands research opportunities on a national scale, the ultimate goal is improved patient outcomes.

As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide aimed at transforming the treatment of Type 2 diabetes and related cardiovascular and renal comorbidities, the CMCA considers Our Lady of the Lake Heart & Vascular Institute a vital member of the Alliance.

“We are excited to welcome Our Lady of the Lake Heart & Vascular as a Charter Member of the Cardiometabolic Center Alliance,” said Dr. Mikhail Kosiborod, Executive Director of the Cardiometabolic Center Alliance. “Partnering with this dedicated team as they implement a comprehensive, coordinated approach to care in this high-risk patient population ensures that our joint mission of improving the lives of those patients living with cardiometabolic disease continues to move forward.

Our Lady of the Lake’s nine-story, 330,000-square-foot Heart & Vascular Institute brings the highest level of patient care to our Baton Rouge and south Louisiana communities in a single, healing environment. Whether patients need life-saving heart attack care or new, minimally invasive procedures for complex conditions, Our Lady of the Lake Heart & Vascular Institute surgeons can provide the necessary treatment.

“Our Lady of the Lake Heart & Vascular Institute is proud to be a part of the CMCA,” said Dr. Denzil Moraes, chief medical director of Our Lady of the Lake Heart & Vascular Institute. “Type 2 diabetes increases the risk of cardiovascular disease, which is why our team is dedicated to providing a comprehensive approach to treatment. Being part of the CMCA amplifies our work as the Spirit of Healing in the Baton Rouge community.”

The Cardiometabolic Center Alliance currently consists of 15-member health systems and is in discussions with health systems across the United States and internationally.

About The Cardiometabolic Center Alliance

The Cardiometabolic Center Alliance is a national collaborative of healthcare organizations committed to the mission of improving the quality of care and outcomes in patients with cardiometabolic disease. Across its aligned member sites, care is delivered via a standardized, patient-centered, team-based, comprehensive risk-reduction approach based on a novel care model designed and successfully implemented by Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence in Kansas City, Missouri.

Alliance members adopt and implement a novel care model designed and successfully implemented by Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence in Kansas City, Missouri. Based on the initial data, under this model the rates of optimal guideline-directed medical therapy substantially increased over the national average, ensuring that patients with T2D receive care that is aimed at both optimizing diabetes management and providing comprehensive cardiovascular risk reduction with therapies proven to improve outcomes. These results are made possible by a unified team of clinicians from across the disease continuum, who focus on holistic, guideline-directed preventative care. Through their participation, Alliance members also contribute to a national registry that track treatment patterns and quality of care. As the Alliance enhances its capabilities, improves processes, and expands research opportunities on a national scale, the ultimate goal is improved patient outcomes.